Intensity Therapeutics Inc.
INTS | NASDAQ
$3.90
-$0.12 (-2.99%)
Sep 22, 2026, 10:47 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Net Income | -11.61M | -16.27M | -10.54M | -7.58M | -7.9M | -6.03M |
Depreciation & Amortization | n/a | n/a | n/a | 179.04K | n/a | n/a |
Stock-Based Compensation | 2M | 3.07M | 1.4M | 1.17M | 719.82K | 555.49K |
Other Working Capital | -13K | 167K | -2.26M | 326.02K | 210.23K | 159.22K |
Other Non-Cash Items | 26K | 76K | 2.57M | 178.86K | 172.11K | 116.83K |
Deferred Income Tax | n/a | n/a | n/a | -179.04K | n/a | n/a |
Change in Working Capital | 347K | -2.1M | -633K | 756.69K | 176.8K | -12.03K |
Operating Cash Flow | -9.23M | -15.22M | -7.21M | -5.48M | -6.83M | -5.37M |
Capital Expenditures | n/a | n/a | n/a | n/a | 3 | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -3.06M | -15.05M | n/a | n/a | -10.9M |
Sales Maturities Of Investments | n/a | 9.41M | 9.03M | n/a | n/a | 15.46M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | 6.35M | -6.02M | n/a | n/a | 4.56M |
Debt Repayment | n/a | n/a | 230K | 2.25M | 2M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -332K | -2.18M | n/a | 50K | 25K |
Financial Cash Flow | 18.56M | 2.9M | 20.47M | 2.25M | 2.05M | 6.29M |
Net Cash Flow | 9.33M | -5.97M | 7.24M | -3.23M | -4.78M | 5.49M |
Free Cash Flow | -9.23M | -15.22M | -7.21M | -5.48M | -6.83M | -5.37M |
Adj. Free Cash Flow | -11.23M | -18.29M | -8.6M | -6.65M | -7.55M | -5.93M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | 3 | n/a |
Owner Earnings | -9.23M | -15.22M | -7.21M | -5.48M | -6.83M | -5.37M |
Add to Watchlist
Select watchlists to add or remove INTS